Number of acquired melanocytic nevi in patients with melanoma and control subjects in Japan: Nevus count is a significant risk factor for nonacral melanoma but not for acral melanoma

Journal of the American Academy of Dermatology

Volumn 50, Issue 5, 2004, Pages 695-700

  Rokuhara, Shiho ^a   Saida, Toshiaki ^a   Oguchi, Misae ^a   Matsumoto, Kazuhiko ^a   Murase, Sumio ^a   Oguchi, Shinji ^b  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Nagano Prefectural Federation of Agricultural Cooperative for Health and Welfare   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOOT SOLE; HAND PALM; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MELANOCYTIC NEVUS; MELANOMA; NAIL; POPULATION RESEARCH; PRIORITY JOURNAL; RISK FACTOR;

EID: 2342457782     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2003.11.053     Document Type: Article

References (31)

1. Ishihara K, Saida T, Yamamoto A. Updated statistical data for malignant melanoma in Japan. Int J Clin Oncol 2001;6:109-16.
2. Bauer J, Garbe C. Acquired melanocytic nevi as risk factor for melanoma development: a comprehensive review of epidemiological data. Pigment Cell Res 2003;16:297-306.
3. Carli P, Biggeri A, Giannotti B. Malignant melanoma in Italy: risks associated with common and clinically atypical melanocytic nevi. J Am Acad Dermatol 1995;32:734-9.
4. Naldi L, Lorenzo Imberti G, Parazzini F, Gallus S, La Vecchia C. Pigmentary traits, modalities of sun reaction, history of sunburns, and melanocytic nevi as risk factors for cutaneous malignant melanoma in the Italian population. Cancer 2000;88:2703-10.
5. Bataille V, Grulich A, Sasieni P, Swerdlow A, Newton-Bishop J, McCarthy W, et al. The association between naevi and melanoma in population with different levels of sun exposure: a joint case-control study of melanoma in the UK and Australia. Br J Cancer 1998;77:505-10.
6. Grulich AE, Bataille V, Swerdlow AJ, Newton-Bishop JA, Cuzick J, Hersey P, et al. Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales, Australia. Int J Cancer 1996;67:485-91.
7. Gallagher RP, Rivers JK, Yang CP. Melanocytic nevus density in Asian, Indo-Pakistani, and white children: the Vancouver mole study. J Am Acad Dermatol 1991;25:507-12.
8. Kim YG, Cho KH. Counts of common and atypical melanocytic nevi in Korean young men: assessment of their risks and correlation with associated factors. J Dermatol 1996;23:315-9.
9. Clark WH Jr, Goldman LI, Mastrangelo MJ. Human malignant melanoma. New York: Grune and Stratton; 1979.
10. Burd DAR. Burns. In: Champion RH, Burton JL, Burns DA, Breathnach SM, editors. Rook/Wilkinson/Ebling textbook of dermatology. Vol 1. 6th ed. Oxford: Blackwell Science; 1998. p. 938-55.
11. Pope DJ, Sorahan T, Marsden JR, Ball PM, Grimley RP, Peck IM. Benign pigmented nevi in children: prevalence and associated factors: the west midlands, United Kingdom mole study. Arch Dermatol 1992;128:1201-6.
12. Gallagher RP, McLean DI. The epidemiology of acquired melanocytic nevi. Dermatol Clin 1995;13:595-603.
13. English DR, Armstrong BK. Melancytic nevi in children. Am J Epidemiol 1994;139:390-401.
14. Katsambas A, Nicolaidou E. Cutaneous malignant melanoma and sun exposure. Arch Dermatol 1996;132:444-50.
15. Augustsson A. Melanocytic naevi, melanoma and sun exposure. Acta Derm Venereol 1991;166:1-34.
16. Armstrong BK, de Klerk NH, Holman CD. Etiology of common acquired melanocytic nevi: constitutional variables, sun exposure, and diet. J Natl Cancer Inst 1986;77:329-35.
17. Augustsson A, Stierner U, Rosdahl I, Suurkula M. Regional distribution of melanocytic naevi in relation to sun exposure, and site-specific counts predicting total number of naevi. Acta Derm Venereol 1992;72:123-7.
18. Autier P, Dore JF, Cattaruzza MS, Renard F, Luther H, Gentiloni-Silverj F, et al. Sunscreen use, wearing clothes, and number of nevi in 6- to 7-year-old European children. J Natl Cancer Inst 1998;90:1873-80.
19. Harrison SL, Buettner PG, MacLennan R. Body-site distribution of melanocytic nevi in young Australian children. Arch Dermatol 1999;135:47-52.
20. Gallagher RP, McLean DI, Yang CP, Coldman AJ, Silver HK, Spinelli JJ, et al. Anatomic distribution of acquired melanocytic nevi in white children: the Vancouver mole study. Arch Dermatol 1990;125:466-71.
21. Farinas-Alvarez C, Rodenas JM, Herranz MT, Delgado-Rodriguez M. The naevus count on the arms as a predictor of the number of melanocytic naevi on the whole body. Br J Dermatol 1999;140: 457-62.
22. Fritschi L, McHenry P, Green A, MacKie R, Green L, Siskind V. Naevi in schoolchildren in Scotland and Australia. Br J Dermatol 1994;130:599-603.
23. Karlsson P, Stenberg B, Rosdahl I. Prevalence of pigmented naevi in a Swedish population living close to the Arctic Circle. Acta Derm Venereol 2000;80:335-9.
24. Darlington S, Siskind V, Green L, Green A. Longitudinal study of melanocytic nevi in adolescents. J Am Acad Dermatol 2002;46: 715-22.
25. Kelly JW, Rivers JK, MacLennan R, Harrison S, Lewis AE, Tate BJ. Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren. J Am Acad Dermatol 1994;30:40-8.
26. Indsto JO, Cachia AR, Kefford RF, Mann GJ. X inactivation, DNA deletion, and microsatellite instability in common acquired melanocytic nevi. Clin Cancer Res 2001;7:4054-9.
27. Hui P, Perkins A, Glusac E. Assessment of clonality in melanocytic nevi. J Cutan Pathol 2001;28:140-4.
28. Grob JJ, Gouvernet J, Aymar D, Mostaque A, Romano MH, Collet AM, et al. Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer 1990;66:387-95.
29. Rodenas JM, Delgado-Rodriguez M, Farinas-Alvarez C, Herranz MT, Serrano S. Melanocytic nevi and risk of cutaneous malignant melanoma in southern Spain. Am J Epidemiol 1997;145:1020-9.
30. Garbe C, Buttner P, Weiss J, Soyer HP, Stocker U, Kruger S, et al. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case-control study of the central malignant melanoma registry of the German dermatological society. J Invest Dermatol 1994;102:695-9.
31. Tucker MA, Halpern A, Holly EA, Hartge P, Elder DE, Sagebiel RW, et al. Clinically recognized dysplastic nevi: a central risk factor for cutaneous melanoma. JAMA 1997;277:1439-44.